ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1901

Reduced SPAG17 Expression Links Dysfunctional Cilia, Morphogen Signaling Activation and Multiple Organ Fibrosis: Novel Target for Systemic Sclerosis

Paulene Sapao1, Bo Shi2, Elisha D.O. Roberson3, John Atkinson4, Jerome Strauss1, Maria Teves1 and John Varga2, 1Virginia Commonwealth University, Richmond, VA, 2Northwestern University, Chicago, IL, 3Depts. of Medicine and Genetics, Division of Rheumatology, Washington University, St. Louis, MO, 4Medicine/Rheumatology, Washington University School of Medicine, St. Louis, MO

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: fibrosis and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: 4M109 ACR Abstract: Systemic Sclerosis & Rel D/Os–Basic Science (1899–1904)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Persistent myofibroblast activation driving progressive fibrosis is the defining hallmark of systemic sclerosis (SSc). Uniquely, fibrosis in SSc affects the skin, heart, lungs and muscles synchronously, suggesting that pathways shared across multiple target organs could be responsible. However, the nature of the fundamental alteration common to distinct organs affected in SSc patients remains unknown. In order to identify novel therapeutic targets, we sought potential novel mechanisms accounting for multi-organ fibrosis.

Methods: We performed next generation sequencing on skin biopsies from patients with SSc (n=19) and matched healthy controls (n=14). Expression of differentially regulated genes in the skin was investigated by immunohistochemistry. Novel knockout mice were generated and at various ages analyzed for fibrosis. Regulation of morphogen signaling and fibrotic responses was examined in cell culture assays using null fibroblasts.

Results: Unbiased RNAseq transcriptome analysis identified SPAG17 as the most differentially-expressed gene in SSc skin biopsies (-4.18 fold; p< 0.0001). SPAG17 is a primary cilia gene with unknown function, previously linked to human height in GWAS. Levels of SPAG17 mRNA in SSc skin biopsies showed negative correlation with the Modified Rodnan Skin Score; low SPAG17 expression was associated with increased morphogen (Hedgehog, Wnt) activity (elevated Smoothened and Dishevelled1) in the skin. Immunofluorescence analysis of SSc skin biopsies demonstrates marked reduction in SPAG17 expression, and absence of SPAG17 in lesional myofibroblasts. SPAG17-deficient myofibroblasts had stunted and dysfunctional primary cilia, and showed constitutive activation of Smad pathways. Moreover, loss of SPAG17 rendered fibroblasts exquisitely sensitive to TGF-ß. Since SPAG17 knockout mice generated in our lab die in the perinatal period due to severe lung involvement, we crossed SPAG17fl mice with Sox-Cre mice. The offspring survive into adulthood, and are indistinguishable for their wildtype littermates. Remarkably, by 4-6 months of age, SPAG17-deficient mice show notable fibrosis in skin, heart, lungs, kidney and skeletal muscle.

Conclusion: The ciliary gene SPAG17 appears to play a critical role in preventing fibrosis in multiple organs. Loss of SPAG17 renders fibroblasts markedly susceptible to fibrotic stimulation, and is associated with spontaneous scleroderma-like skin changes accompanied by fibrosis in multiple organs. Reduced expression of SPAG17 and consequent ciliary dysfunction and augmented morphogen signaling therefore appear to play a previously unrecognized role in fibrosis and could contribute to the pathogenesis of SSc. SPAG 17 KO mice represent a unique novel disease model phenocopying synchronous fibrosis in multiple organs.


Disclosure: P. Sapao, None; B. Shi, None; E. D. O. Roberson, None; J. Atkinson, None; J. Strauss, None; M. Teves, None; J. Varga, BSM, 2,Pfizer, Inc., 2,Boehringer, 5,Mitsubishi, 5,Corbus, 5,Scleroderma Foundation, 6.

To cite this abstract in AMA style:

Sapao P, Shi B, Roberson EDO, Atkinson J, Strauss J, Teves M, Varga J. Reduced SPAG17 Expression Links Dysfunctional Cilia, Morphogen Signaling Activation and Multiple Organ Fibrosis: Novel Target for Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/reduced-spag17-expression-links-dysfunctional-cilia-morphogen-signaling-activation-and-multiple-organ-fibrosis-novel-target-for-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reduced-spag17-expression-links-dysfunctional-cilia-morphogen-signaling-activation-and-multiple-organ-fibrosis-novel-target-for-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology